http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 25 Aug 2026 10:13:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+Funding+Update/26972487.html <p>HENDERSON, Nev., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) is continuing its ongoing negotiation with investors from Thailand, Japan, Switzerland, Luxembourg, USA, Bulgaria, and the UAE for financing of up to 50 million US dollars. The Company has seen great interest, with most investors reaching out directly to NIKA.</p> <p align="justify">“We are striving to select the most suitable investor and partner for NIKA, for which reason the discussions surrounding the technical details of the potential deals are taking more time”, stated CEO Dimitar Savov. “We are expecting to have made our final decision and http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+Funding+Update/26972487.html Tue, 25 Aug 2026 10:13:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+Funding+Update/26972487.html <p>HENDERSON, Nev., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) is continuing its ongoing negotiation with investors from Thailand, Japan, Switzerland, Luxembourg, USA, Bulgaria, and the UAE for financing of up to 50 million US dollars. The Company has seen great interest, with most investors reaching out directly to NIKA.</p> <p align="justify">“We are striving to select the most suitable investor and partner for NIKA, for which reason the discussions surrounding the technical details of the potential deals are taking more time”, stated CEO Dimitar Savov. “We are expecting to have made our final decision and http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+Funding+Update/26972487.html Tue, 25 Aug 2026 10:13:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+Funding+Update/26972487.html <p>HENDERSON, Nev., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) is continuing its ongoing negotiation with investors from Thailand, Japan, Switzerland, Luxembourg, USA, Bulgaria, and the UAE for financing of up to 50 million US dollars. The Company has seen great interest, with most investors reaching out directly to NIKA.</p> <p align="justify">“We are striving to select the most suitable investor and partner for NIKA, for which reason the discussions surrounding the technical details of the potential deals are taking more time”, stated CEO Dimitar Savov. “We are expecting to have made our final decision and http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+Funding+Update/26972487.html Tue, 25 Aug 2026 10:13:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+Funding+Update/26972487.html <p>HENDERSON, Nev., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) is continuing its ongoing negotiation with investors from Thailand, Japan, Switzerland, Luxembourg, USA, Bulgaria, and the UAE for financing of up to 50 million US dollars. The Company has seen great interest, with most investors reaching out directly to NIKA.</p> <p align="justify">“We are striving to select the most suitable investor and partner for NIKA, for which reason the discussions surrounding the technical details of the potential deals are taking more time”, stated CEO Dimitar Savov. “We are expecting to have made our final decision and http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+Funding+Update/26972487.html Tue, 25 Aug 2026 10:13:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Jun+30/26896808.html si-local-file:///var/storage/secattach/20260810/26896808.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Jun+30/26896808.html Mon, 10 Aug 2026 13:39:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Jun+30/26896808.html si-local-file:///var/storage/secattach/20260810/26896808.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Jun+30/26896808.html Mon, 10 Aug 2026 13:39:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html <p align="justify">HENDERSON, Nev., June 04, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) is currently engaged in active discussions with several investors from Europe and the US who have demonstrated significant interest in NIKA; negotiations with two of these parties are in advanced stages.</p> <p align="justify">Because NIKA’s goal is not only to secure financing but also to gain a strong strategic partner, the negotiations take slightly more time; however, strong investor interest gives the Company the opportunity to secure the best possible investor.</p> <p align="justify">After the necessary funds have been secured, the pharmaceutical factory will be http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html Thu, 04 Jun 2026 10:10:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html <p align="justify">HENDERSON, Nev., June 04, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) is currently engaged in active discussions with several investors from Europe and the US who have demonstrated significant interest in NIKA; negotiations with two of these parties are in advanced stages.</p> <p align="justify">Because NIKA’s goal is not only to secure financing but also to gain a strong strategic partner, the negotiations take slightly more time; however, strong investor interest gives the Company the opportunity to secure the best possible investor.</p> <p align="justify">After the necessary funds have been secured, the pharmaceutical factory will be http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html Thu, 04 Jun 2026 10:10:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html <p align="justify">HENDERSON, Nev., June 04, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) is currently engaged in active discussions with several investors from Europe and the US who have demonstrated significant interest in NIKA; negotiations with two of these parties are in advanced stages.</p> <p align="justify">Because NIKA’s goal is not only to secure financing but also to gain a strong strategic partner, the negotiations take slightly more time; however, strong investor interest gives the Company the opportunity to secure the best possible investor.</p> <p align="justify">After the necessary funds have been secured, the pharmaceutical factory will be http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html Thu, 04 Jun 2026 10:10:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html <p align="justify">HENDERSON, Nev., June 04, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) is currently engaged in active discussions with several investors from Europe and the US who have demonstrated significant interest in NIKA; negotiations with two of these parties are in advanced stages.</p> <p align="justify">Because NIKA’s goal is not only to secure financing but also to gain a strong strategic partner, the negotiations take slightly more time; however, strong investor interest gives the Company the opportunity to secure the best possible investor.</p> <p align="justify">After the necessary funds have been secured, the pharmaceutical factory will be http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html Thu, 04 Jun 2026 10:10:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Mar+31/26477144.html si-local-file:///var/storage/secattach/20260512/26477144.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Mar+31/26477144.html Tue, 12 May 2026 15:19:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Mar+31/26477144.html si-local-file:///var/storage/secattach/20260512/26477144.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Mar+31/26477144.html Tue, 12 May 2026 15:19:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Dec+31/26216937.html si-local-file:///var/storage/secattach/20260325/26216937.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Dec+31/26216937.html Wed, 25 Mar 2026 15:47:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Dec+31/26216937.html si-local-file:///var/storage/secattach/20260325/26216937.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Dec+31/26216937.html Wed, 25 Mar 2026 15:47:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html <p align="justify">HENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) appeared on <em>The Street Reports </em>podcast where CEO Dimitar Savov shared the progress the company has made thus far and outlined what is expected for 2026, which will be a crucial year for the company. You may listen to the podcast episode <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ndWtDqwJ4lETkhM1qT1P18VMK6CceX3BEUlKjMC8D1VBvqUqPI2QiWUl7I3AxIajd1fkztJLmieBVYdgLLvNAkxtggu2ymymoMilFt8q8BujUbTVL0Z3Wl081ZpUQ10zbZ33sxCyx6m2nwPWEWQX_xOAAuDrUaJq7cQsyXrbmVwwXAkxDcauD7IuwqR0iKOsByCHSAeaXOsuStspEZa2L5H2320kiz1CFe-uGOFBbQJcB6QiD_FG3m3ifvhUuvt9" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Additionally, NIKA’s partner, Nika Europe, is finalizing the technical project for the pharmaceutical factory and expects to begin construction soon. Given that the factory is a “building within a building”, the build up time will http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html Wed, 03 Dec 2025 11:58:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html <p align="justify">HENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) appeared on <em>The Street Reports </em>podcast where CEO Dimitar Savov shared the progress the company has made thus far and outlined what is expected for 2026, which will be a crucial year for the company. You may listen to the podcast episode <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ndWtDqwJ4lETkhM1qT1P18VMK6CceX3BEUlKjMC8D1VBvqUqPI2QiWUl7I3AxIajd1fkztJLmieBVYdgLLvNAkxtggu2ymymoMilFt8q8BujUbTVL0Z3Wl081ZpUQ10zbZ33sxCyx6m2nwPWEWQX_xOAAuDrUaJq7cQsyXrbmVwwXAkxDcauD7IuwqR0iKOsByCHSAeaXOsuStspEZa2L5H2320kiz1CFe-uGOFBbQJcB6QiD_FG3m3ifvhUuvt9" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Additionally, NIKA’s partner, Nika Europe, is finalizing the technical project for the pharmaceutical factory and expects to begin construction soon. Given that the factory is a “building within a building”, the build up time will http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html Wed, 03 Dec 2025 11:58:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html <p align="justify">HENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) appeared on <em>The Street Reports </em>podcast where CEO Dimitar Savov shared the progress the company has made thus far and outlined what is expected for 2026, which will be a crucial year for the company. You may listen to the podcast episode <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ndWtDqwJ4lETkhM1qT1P18VMK6CceX3BEUlKjMC8D1VBvqUqPI2QiWUl7I3AxIajd1fkztJLmieBVYdgLLvNAkxtggu2ymymoMilFt8q8BujUbTVL0Z3Wl081ZpUQ10zbZ33sxCyx6m2nwPWEWQX_xOAAuDrUaJq7cQsyXrbmVwwXAkxDcauD7IuwqR0iKOsByCHSAeaXOsuStspEZa2L5H2320kiz1CFe-uGOFBbQJcB6QiD_FG3m3ifvhUuvt9" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Additionally, NIKA’s partner, Nika Europe, is finalizing the technical project for the pharmaceutical factory and expects to begin construction soon. Given that the factory is a “building within a building”, the build up time will http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html Wed, 03 Dec 2025 11:58:00 -0400 NIKA O.61790030